Future treatment regimen by abrogating this trigger and thus blocking region P methylation followed by sustaining RARRES1 expression could potentially improve disease prognosis via hampering metastasis, the common cause of death in a wide range of human carcinomas including breast cancer. This evidence concerns the gene RARRES1 and breast carcinoma.